Transcatheter heart valve with variable geometric configuration: In vitro evaluation

Artificial Organs

Volumn 35, Issue 12, 2011, Pages 1151-1159

  Young, Ernest ^a,b   Chen, Ji Feng ^b   Dong, Owen ^c   Gao, Shengqiang ^b   Massiello, Alex ^b   Fukamachi, Kiyotaka ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c School of Operations Research and Industrial Engineering   (United States)

Author keywords

Heart valve Transapical Percutaneous Aortic valve calcification In vitro studies

Indexed keywords

BLOOD VESSELS; BONE; GEOMETRY; HYDRODYNAMICS;

AORTIC VALVES; EFFECTIVE ORIFICE AREAS; GEOMETRIC CONFIGURATIONS; HEART VALVE-TRANSAPICAL-PERCUTANEOUS-AORTIC VALVE CALCIFICATION-IN VITRO STUDY; HEART VALVES; IN-VITRO; TRANSCATHETER AORTIC VALVES; TRANSVALVULAR PRESSURE GRADIENTS; VALVE CALCIFICATION; VITRO STUDIES;

BIOMINERALIZATION;

AORTA VALVE REGURGITATION; AORTIC ANNULOPLASTY; ARTICLE; GEOMETRY; HEART HEMODYNAMICS; HUMAN; HYDRODYNAMICS; IN VITRO STUDY; PRESSURE GRADIENT; PRIORITY JOURNAL; TRANSCATHETER AORTIC VALVE IMPLANTATION;

TOMATO ASPERMY VIRUS;

EID: 83855164082     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01331.x     Document Type: Article

References (27)

1. Cribier A, Eltchaninoff H, Bash A, etal. Percutaneous transcatheter implantation of aortic valve prosthesis for calcific aortic stenosis; first human case description. Circulation 2002;106:3006-8.
2. Cribier A, Eltchaninoff H, Tron C, etal. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703.
3. Grube E, Laborde JC, Zickmann B, etal. First report on a human percutaneous transluminal implantation of a self expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465-9.
4. Grube E, Laborde JC, Gerckens U, etal. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-24.
5. Webb JG, Chandavimol M, Thompson CR, etal. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50. Epub February 6, 2006.
6. Walther T, Falk V, Borger MA, etal. Minimally invasive transapical beating heart aortic valve implantation-proof of concept. Eur J Cardiothorac Surg 2007;31:9-15. Epub November 9, 2006.
7. Webb JG, Altwegg L, Masson JB, Al Bugami S, Al Ali A, Boone RA. A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009;53:1855-8.
8. Zegdi R, Ciobotaru V, Noghin M, etal. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008;51:579-84.
9. Zegdi R, Blanchard D, Achouh P, etal. Deployed Edwards Sapien prosthesis is always deformed. J Thorac Cardiovasc Surg 2010;140:e54-6.
10. Wood DA, Tops LF, Mayo JR, etal. Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 2009;103:1295-301.
11. Blanke P, Siepe M, Reinöhl J, etal. Assessment of aortic annulus dimensions for Edwards SAPIEN transapical heart valve implantation by computed tomography: calculating average diameter using a virtual ring method. Eur J Cardiothorac Surg 2010;38:750-8. Epub May 14, 2010.
12. Schultz CJ, Weustink A, Piazza N, etal. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J Am Coll Cardiol 2009;54:911-8.
13. Koos R, Mahnken AH, Dohmen G, etal. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 2010;150:142-5.
14. John D, Buellesfeld L, Yuecel S, etal. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding CoreValve prosthesis. JACC Cardiovasc Interv 2010;3:233-43.
15. Ussia GP, Barbanti M, Tamburino C. Consequences of underexpansion of a percutaneous aortic valve bioprosthesis. J Invasive Cardiol 2010;22:E86-9.
16. FDA. Test Protocol: Interlaboratory Comparison of Prosthetic Heart Valve Performance Testing. Rockville, ML: FDA, 1985.
17. Marquez S, Hon RT, Yoganathan AP. Comparative hydrodynamic evaluation of bioprosthetic heart valves. J Heart Valve Dis 2001;10:802-11.
18. Kuehnel RU, Wendt MO, Jainski U, Hartrumpf M, Pohl M, Albes JM. Suboptimal geometrical implantation of biological aortic valves provokes functional deficits. Interact Cardiovasc Thorac Surg 2010;10:971-5. Discussion, 975. Epub March 16, 2010.
19. International Organization for Standardization. Cardiovascular implants-cardiac valve prostheses. EN ISO 5840:2005 (E); 2005.
20. Yoganathan AP, Leo HL, Travis B, Teoh S-H. Heart valve prostheses. In: Milne I, Ritchie RO, Karihaloo BL, eds. Comprehensive Structural Integrity, vol. 9, ch. 9.07. Boston, MA: Elsevier Science, 2003;297-328.
21. Delgado V, Ng AC, van de Veire NR, etal. Transcatheter aortic valve implantation: role of multi-detector row computed tomography to evaluate prosthesis positioning and deployment in relation to valve function. Eur Heart J 2010;31:1114-23. Epub February 19, 2010.
22. Zahn R, Schiele R, Kilkowski C, Zeymer U. Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 2010;99:193-7. Epub December 30, 2009.
23. Piazza N, Grube E, Gerckens U, etal. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System-results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-9.
24. Webb JG, Pasupati S, Humphries K, etal. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63. Epub July 23, 2007.
25. Cribier A, Eltchaninoff H, Tron C, etal. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23. Epub February 9, 2006.
26. Grube E, Schuler G, Buellesfeld L, etal. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. Epub June 6, 2007.
27. Bauer F, Lemercier M, Zajarias A, Tron C, Eltchaninoff H, Cribier A. Immediate and long-term echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis: the Cribier-Edwards/Edwards-Sapien valve experience. J Am Soc Echocardiogr 2010;23:370-6.